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Abstract
Background The aim of the study was to establish longitu-
dinal bone changes in obese women after laparoscopic
sleeve gastrectomy (LSG).
Methods Twenty-nine women at baseline mean age of
40.41±9.26 years and with mean body mass index (BMI)
of 43.07±4.99 kg/m
2 were included in a 6-month study.
Skeletal status at hip [femoral neck (FN) and total hip
(TH)] and spine was assessed at baseline, as well as in 3
and 6 months after surgery. Body size was measured at
baseline and follow-up (weight, height, BMI, and waist).
Results Baseline body weight was 117.5±18.4 kg. The mean
body weight and BMI decreased by 17.9 % during the first
3 months after surgery to obtain 28.4 % after 6 months. At
6 months, BMD decreased significantly for spine by 1.24 %,
FN 6.99 %, and TH 5.18 %. The changes after 3 months in
individual subjects showed that, in the majority of subjects,
FN and TH BMD decreased significantly (in 52 % and 69 %
ofsubjects,respectively),andin24%lossofBMDwasfound
at the spine. After 6 months, the corresponding, significant
decreases in individual subjects were found in 72 %, 86 %,
and 38 % of women, respectively. Those with a significant
loss of FN BMD tended to lose more weight (30±9.47 versus
23.25±6.08 kg, p00.061) than others; women with a signif-
icant decrease of FN BMD lost more weight than those with
no such decrease (30.43±8.07 versus 15±1.91 kg).
Conclusion LSG proved efficient for body weight reduc-
tion, however, with a parallel decline in bone mineral
density.
Keywords Bonemineraldensity .Obesity .Laparoscopic
sleevegastrectomy .Women
Introduction
Obesity is a growing medical and social problem world-
wide. Several health complications are common among
subjects with obesity, especially when the body mass index
(BMI) exceeds 40 kg/m
2. In a significant part of obese
subjects, modifications of lifestyle and pharmacotherapy fail
to bring about expected, significant weight loss. Bariatric
surgery has proven to be the most effective way of treatment
for morbidly obese women and men [1] and may be a cost-
effective alternative treatment in morbid obesity [2]. The
prevalence of weight-related morbid conditions decreases
W. Pluskiewicz (*)
Metabolic Bone Diseases Unit,
Department and Clinic of Internal Diseases,
Diabetology and Nephrology,
Medical University of Silesia in Katowice,
ul. 3-Maja 13/15,
41-800 Zabrze, Poland
e-mail: osteolesna@poczta.onet.pl
M. Bužga: V. Šmajstrla
Department of Physiology, Medical Faculty,
University of Ostrava,
Ostrava, Czech Republic
P. Holéczy
Department of Surgical Disciplines, Medical Faculty,
University of Ostrava,
Ostrava, Czech Republic
L. Bortlík
Bone Densitometry Laboratory, Bormed,
Ostrava, Czech Republic
P. Adamczyk
Department and Clinic of Pediatrics,
Medical University of Silesia,
Katowice, Poland
OBES SURG (2012) 22:1068–1076
DOI 10.1007/s11695-012-0654-8significantly after bariatric surgery [3]. Many different sur-
gical techniques are used in obese patients, including pure
restriction surgery (gastric banding, vertical banded gastro-
plasty, and sleeve gastrectomy) and malabsorption surgery,
either with or without associated restrictions [Roux-en-Y
gastric bypass –(RYGBP), duodenal switch, and bilio-
pancreatic diversion]. However, bariatric surgery, while be-
ing effective for weight loss, may also result in several
health complications, including bone metabolism and status
[1]. In several already published reports, the role of this
treatment method was approached from the bone health
perspective [4–13]. In some studies, BMD changes were
followed up in subjects after RYGBP [4–9], biliopancreatic
diversion [10, 11], or gastric banding [12, 13]. RYGBP, a
very efficient technique, promotes significant changes in
gastrointestinal anatomy, leading to nutritional and metabol-
ic balance [14, 15].
Lately, an increasing interest has been observed regarding
other surgical techniques used in bariatric patients. For
example, laparoscopic sleeve gastrectomy (LSG) is a tech-
nique which changes the gastrointestinal status. In several
recently published studies, LSG was compared with
RYGBP, and both procedures led to comparable weight loss,
associated with the resolution of the metabolic syndrome
[16–19]. One may only expect that the bariatric procedure is
associated with fewer disturbances regarding bone metabo-
lism and status. To our knowledge, the effects of this surgi-
cal technique on bone metabolism and status were studied in
only one small study [20]. The aim of the current study was
then to establish longitudinal bone changes in individual
women after LSG.
Materials and Methods
Twenty-nine (29) obese women at mean baseline age of
41.1±9.78 years were included into the study. They were
recruited from the Department of Obesitology at the Vitko-
vice Hospital in Ostrava, the Czech Republic, and submitted
to bariatric surgery in order to have their body weight
reduced. Table 1 presents clinical characteristics of the stud-
ied women. The majority of them were at premenopausal,
and four (13.3 %) were at postmenopausal age. None of the
examined women presented with concomitant diseases,
which could have potentially influenced their bone metabo-
lism. The subjects were operated during the period of Sep-
tember/December 2010, as part of an open prospective
clinical pilot study monitoring the metabolic response of
lipid and bone tissue, following LSG. After the surgery,
patients enrolled in the study were not included in subse-
quent rehabilitation exercises. The rate of physical activity
has been studied neither in terms of aerobic exercise nor
strength training. During the observation period of 6 months,
four women were excluded from the study (reoperation and
noncompliance).
Surgery
All the women underwent LSG as a restrictive bariatric
procedure, which involves subtotal gastric resection of the
fundus and body to create a long, tubular gastric conduit,
constructed along the lesser curve of the stomach. It was
originally described as the first stage bariatric procedure,
followed by Roux-Y gastric bypass or biliopancreatic diver-
sion with duodenal switch in high-risk patients. However,
given the benefits of low risk, simple surgery with possible
surgical revision when required, more and more bariatric
surgeons accept it as the primary bariatric procedure.
The selection for surgical treatment was made in accor-
dance with the IFSO guidelines, i.e., in individuals with
BMI >40 kg/m
2 or of BMI >35/m
2 with comorbidities.
The study was approved by the Ethical Committee at the
Medical Faculty of the Ostrava University. The patients
were operated at the Bariatric Center of the Vitkovice Hos-
pital in Ostrava, the Czech Republic. The studied women
were subject of long-term observations, and all the proce-
dures, as described in the study report, were performed at
baseline (before the surgery) and after 3 and 6 months.
The operation was performed in general anesthesia at
supine position. Pneumoperitoneum was made using a Ver-
ess needle. A 30 ° laparoscope was used. The area of
diaphragmatic hiatus was revised in detail. Should hiatus
hernia have been found, hiatoplasty was performed. The
subsequent step involved mobilization of the greater curva-
ture of the stomach, which started proximally, 4 cm from the
pylorus. That step was made by an ultrasound dissector
(Harmonic Ace, Johnson and Johnson, Cincinnati, OH,
USA). The mobilization stretched as far as to the left dia-
phragmatic crus. Following satisfactory mobilization, the
stomach was longitudinally resected. The resection was
done by means of an Echelon endoscopic stapler (Johnson
and Johnson, Cincinnati, OH, USA) with blue cartridges of
60 mm length. The size of the left stomach portion was
subject to anatomic border—the end of the short gastric
vessel from the lesser curvature of the stomach. In that phase
of the operation, neither calibration bougie was applied nor
reinforcement of the resection line was used.
Body Size
In all the women, the following body size measurements
were obtained: body weight, body height, abdominal waist
circumference (halfway last rib and the iliac crest), and hip
circumference. In order to determine the weight and height,
an anthropometric calibrated meter was used. Body weight
was measured in volunteers in their underwear with
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was 0.1 cm. All the measurements were performed by a
nurse trained in anthropometric measurements.
Bone Densitometry
Bone densitometry was performed using a Hologic Discovery
W machine (USA). Spine and proximal femur [femoral neck
(FN) and total hip (TH)] bone mineral density (BMD) was
measured. The machine was calibrated, according to the man-
ufacturer's recommendations. A precision error was also
established for the densitometer. CV% was established for
that device, and for FN, TH, and spine, a series of measure-
ments was performed in 15 patients with repositioning. CV%
values were calculated, according to the following formula:
CV%0SD/mean×100 %. CV% values were 0.66 %, 1.49 %,
and 0.74 % for spine, FN, and TH, respectively.
Statistics
All the analyses were performed using the Statistica pro-
gram (StatSoft, Inc., Tulsa, OK, USA). Descriptive statistics
was presented as mean values, standard deviations, and
value ranges. The distribution of analyzed data was checked
by the Shapiro–Wilk test. The differences between results,
obtained at baseline and at follow-up, were established,
using Student's t test for dependent samples. A correlation
analysis at baseline and follow-up was done by Pearson's or
Spearman's test, whichever was appropriate. Individual
differences between baseline and follow-up measurements,
expressed as Δ of the measured variables, were established,
and a correlation analysis was performed for them, using
also Pearson's or Spearman's correlation test, whichever was
appropriate. In order to follow reliable changes of densito-
metric variables in individual patients, the least significant
change (LSC) was calculated. The LSC, or a critical differ-
ence, denotes the minimal difference between two succes-
sive results in an individual that can be considered to reflect
a real change. The LSC was calculated, using the following
formula: RMS_CV×2×1.41, which represent a statistical
difference at the 95 % confidence level [21]. P value lower
than 0.05 was considered as statistically significant.
Results
Changes in Body Size
All the measured body size variables were significantly
lower after 3 and 6 months (Table 1). Table 2 shows differ-
ences, expressed as Δ in body size and densitometric vari-
ables, recorded over the observation period. In general, a
decrease was observed mostly during the first 3 months. For
example, total body weight loss during the first 3 months
was by 17.9 %, falling to 6.2 % during another 3 months.
Figure 1 presents a decrease in excessive body weight after
3 and 6 months.
Table 1 Clinical characteristics, body size, and densitometric variables at baseline and after 3 and 6 months, expressed as means and SDs
Variable Baseline After 3 months After 6 months
Mean ± SD Mean ± SD p value vs.
baseline
examination
Mean ± SD p value vs.
baseline
examination
p value vs.
examination
after 3 months
Weight [kg] 117.5±18.4 96.44±17.76 <0.000001 89.2±16.06 <0.000001 <0.000001
Excess body weight [%] 92.15±23.4 57.6±24.4 <0.000001 45.7±21.8 <0.000001 <0.000001
Height [cm] 164.9±7.39 164.98±7.4 NS 164.98±7.4 NS NS
BMI [kg/m
2] 43.01±4.99 35.31±5.28 <0.000001 32.56±4.75 <0.000001 <0.000001
Waist [cm] 112.7±10.51 98.44±10.37 <0.000001 93.96±9.14 <0.000001 <0.0001
Hips [cm] 136.3±11.64 121.9±12.91 <0.000001 116.9±12.21 <0.000001 <0.00001
Spine BMD [g/cm
2] 1.163±0.15 1.165±0.15 NS 1.148±0.16 <0.05 <0.001
T-score 1.05±1.39 1.07±1.41 NS 0.92±1.42 <0.05 <0.001
Z-score 1.45±1.51 1.49±1.53 NS 1.33±1.52 <0.05 <0.001
FN BMD [g/cm
2] 0.988±0.14 0.94±0.12 <0.00001 0.917±0.11 <0.000001 <0.0001
T-score 1.26±1.29 0.84±1.1 <0.00001 0.59±1.01 <0.000001 <0.0001
Z-score 1.68±1.25 1.27±1.11 <0.00001 1.04±1.02 <0.000001 <0.0001
TH BMD [g/cm
2] 1.135±0.12 1.095±0.12 <0.000001 1.07±0.11 <0.000001 <0.0001
T-score 1.57±0.98 1.25±0.99 <0.000001 1.11±0.95 <0.000001 <0.001
Z-score 1.85±1.01 1.55±1.05 <0.000001 1.39±1.03 <0.000001 <0.001
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The mean BMD values decreased significantly for spine,
FN, and TH over the observation period. Densitometric data
are presented in Table 1. During the first 3 months of
observation, the mean FN and TH BMD values decreased
significantly by 4.45 % and 3.5 %, respectively, while the
spine BMD remained stable. Further, some decrease was
observed for all the observed skeletal sites. In general, a
decline for the proximal femur was more distinct during the
first 3 months. The mean spine BMD value decreased sig-
nificantly by 1.24 %, FN BMD by 6.99 %, and TH BMD by
5.18 % over the observation period. Taking into account the
whole period of observation, the spine BMD decrease was
significantly smaller than BMD decrease for FN (p<
0.00001) or TH (p<0.00001), and the decrease in FN
BMD was significantly bigger than for TH (p<0.01). The
values of T-score and Z-score for spine, FN, and TH were
significantly lower at follow-up (p<0.000001; see Table 1).
Bone Mineral Changes—Results in Individual Patients
An analysis was performed with regards to BMD changes in
individual subjects. The analysis of the mean changes in the
whole group allowed assessing general trends, but when a
longitudinal observation is carried out, one should also take
into consideration the precision of used devices. That analysis
enabled us to find out where (i.e., in which women) BMD
values decreased more than LSC values during 3 and 6 months.
Figures 2, 3, 4 and 5, 6, 7 presented BMD changes in
individual patients after 3 and 6 months, respectively. In all
the figures, the results of individual patients are presented in
the same order. The changes, observed after 3 months in
individualsubjects,confirmedthat,inthemajorityofsubjects,
FN and TH BMD decreased significantly (52 % and 69 %,
respectively), and only in 24 %, regarding BMD at the spine.
SpineBMDincreasewasnotedin24%ofthestudiedwomen.
Figure 5 presents data for spine BMD after 6 months; in 11
patients, BMD decreased (38 %); in 15, it was stable (52 %);
and in 3, it increased (10 %). In the majority of the studied
women, FN BMD decreased (21 patients, 72 %; Fig. 6), and
regarding TH BMD, a decrease was observed in 25 women
(86 %; Fig. 7). Figure 8 shows differences of TH BMD,
expressed in grams per square centimeter.
We also assumed that in women with a significant de-
crease in BMD, there should be a more pronounced decrease
in body weight as well. Those who lost FN BMD tended to
lose more weight (30.0±9.47 versus 23.25±6.08 kg, p0
0.061) than those who did not, and in women with a signif-
icant decrease of TH BMD, there was more weight lost than
in those with no such a decrease (30.43±8.07 versus 15±
1.91 kg). Regarding the changes in spine BMD, no signif-
icant differences were observed in body weight.
Table 2 Changes in body size and densitometric variables after 3 and
6 months, expressed as means and SDs
Variable Δ (difference
between baseline
and 3 months)
Δ (difference
between baseline
and 6 months)
Weight [kg] −21.1±7.21 −28.37±9.15
BMI [kg/m
2] −7.76±2.7 −10.42±3.34
Waist [cm] −14.27±6.73 −18.75±8.27
Hips [cm] −14.3±6.95 −19.37±7.44
Spine BMD [g/cm
2] 0.0023±0.02 −0.014±0.03
FN BMD [g/cm
2] −0.046±0.04 −0.072±0.046
TH BMD [g/cm
2] −0.039±0.02 −0.059±0.03
Fig. 1 Individual values of
excess body weight (expressed
as percentage of ideal weight)
during the period of observation
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A correlation analysis between BMD baseline values and body
size showed a significant relationship between FN BMD with
weight (r00.39,p<0.05) and spineBMD with height (r00.55,
p<0.01). The same analysis after 6 months revealed the fol-
lowing significant correlations: spine BMD with height (r0
0.54, p<0.01) and FN BMD with height (r00.47, p<0.05).
Correlation Analysis Between Changes in Body Size
and Changes in BMD—3 months
Δ values for body size after 3 months were correlated with
Δ values of densitometric variables and showed the
following results: Δ for TH BMD correlated with Δ for
body size (BMI, r00.44, p<0.05; waist 1, r00.45, p<0.05;
waist 2, r00.53, p<0.01; hips, r00.59, p<0.01). Δ for FN
and spine BMD did not correlate with changes in body size.
Correlation Analysis Between Changes in Body Size
and Changes in BMD—6 months
Δ values for body size after 6 months were correlated with Δ
values of densitometric variables and showed the following
results: Δ for FN BMD correlated with Δ for weight (r00.51,
p<0.01),Δfor BMI (r00.51, p<0.01),andΔfor hips (r00.46,
p<0.05); Δ for TH BMD correlated with all Δ for body size
(weight, r00.48, p<0.01; BMI, r00.54, p<0.01; waist 1, r0
Fig. 2 Longitudinal BMD
change for lumbar spine during
the first 3 months of
observation in individual
patients. LS BMD lumbar spine
bone mineral density, LSC least
significant change
Fig. 3 Longitudinal BMD
change for femoral neck during
the first 3 months of
observation in individual
patients. FN BMD femoral neck
bone mineral density, LSC least
significant change
1072 OBES SURG (2012) 22:1068–10760.37, p<0.05;waist2,r00.47, p<0.05; hips, r00.58, p<0.01).
Δ for spine BMD did not correlate with Δ for body size.
Bone Mineral Changes—Normal Value, Osteopenia,
and Osteoporosis
We also established a number of subjects with normal val-
ues, osteopenia, and osteoporosis for measured skeletal sites
at baseline and follow-up. In all the women at baseline, FN
and TH BMD values were within normal limits (T-score
above −1.0), and in two women, T-score was in the range of
osteopenia (T-score between −1.0 and −2.5). At follow-up
regarding spine BMD, two subjects remained osteopenic,
two presented with T-score for FN below a threshold of
−1.0, and for all the women, T-score for TH was normal.
Discussion
To our knowledge, the reported study is the first longitudinal
observation of BMD changes in patients after laparoscopi-
cally performed sleeve gastrectomy. Despite the short dura-
tion of the study, BMD decrease was demonstrated in
various skeletal sites, but we consider that the most impor-
tant clinical findings concerned the changes observed in
individual patients. In a longitudinal observation, the essen-
tial role is played by precision of the used method and,
therefore, a concept of the LSC was included in our analy-
sis. Therefore, we were able to reliably find out real bone
losses. In our opinion, such methodology was not used
before with regards to patients after bariatric surgery. In
some studies, concerning bone changes in various groups
Fig. 4 Longitudinal BMD
change for total hip during the
first 3 months of observation in
individual patients. TH BMD
total hip bone mineral density,
LSC least significant change
Fig. 5 Longitudinal BMD
change for lumbar spine during
6 months of observation in
individual patients. LS BMD
lumbar spine bone mineral
density, LSC least significant
change
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[22–24]. An early decrease in BMD occurred after 3 months
from the surgery for the proximal femur in the majority of
patients and only in one fourth for the spine. For the whole
period of observation, the proximal femur BMD decreased
significantly in the majority of the studied patients, and in
less than half of them, spine bone loss was noted.
In obese subjects after bariatric surgery, the most impor-
tant factor, influencing bone status, is probably the loss of
body weight. Surgical intervention in bariatric patients
should result in decreased body size and LSG, performed
in our patients, confirmed the efficacy of the method. We
assumed that in women with a significant decrease in BMD,
a more pronounced decrease in body weight should be
present. That thesis was supported at borderline significant
level for FN changes and in total for TH bone changes. In
Figs. 1 and 8, changes are shown in body weight and TH
BMD, respectively, and it may be seen that the pattern of
longitudinal changes is similar.
Only one small study compared the results of patients,
operated by SG and RYGBP procedure [20]. Fifteen women
with morbid obesity were included, eight after SG and seven
after RYGBP, their mean age of 47.8±9 years and the mean
BMI of 43.3±3.4 kg/m
2. Densitometry of lumbar spine,
femur, and distal radius was performed before and
12 months after surgery. A significant bone mass loss was
observed in patients after SG and RYGBP surgery in the
lumbar spine and hip, while no differences were observed in
the radial status. The percentage of BMD loss was less in the
spine and femur after SG than with RYGBP, although it did
Fig. 6 Longitudinal BMD
change for femoral neck during
6 months of observation in
individual patients. FN BMD
femoral neck bone mineral
density, LSC least significant
change
Fig. 7 Longitudinal BMD
change for total hip during
6 months of observation in
individual patients. TH BMD
total hip bone mineral density,
LSC least significant change
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tively). The authors concluded that SG caused less, although
not significant, bone mass loss, compared to RYGBP. In the
current study, we noted a clearly smaller decrease for spine
but greater for FN.
We demonstrated that in obese women with the mean
baseline BMI of 43 kg/m
2, successful results of body size
reduction were possible. The mean decrease of 28 % in
baseline body weight was noted in our group, which is
comparable to the results presented by other authors, after
1 year from surgery with gastric banding; four of them noted
a similar weight loss, ranging from 23.3 % [25]t o2 5%[ 12,
13, 26], and only Vilarrasa et al. observed a greater weight
loss of 33.7 % [8]. Some authors presented weight loss after
6 months, and their results of 13 % [4] and 16 % [13, 25]
were smaller than noted in the reported study.
Parallel to expected changes in body weight, also noted
was a significant decrease for spine and proximal femur
BMD. The most significant decline in BMD was observed
for the FN, followed by TH and spine. Relationships were
also established between changes in body size and BMD
(both expressed as Δ), and a bigger decrease in body size
was connected with a more pronounced decline in BMD
values except for those in the spine. Interestingly enough,
only some correlations of body size with densitometric
variables were noted at baseline. The decline in FN was
most pronounced, which is comparable to the data given by
some of the other authors [8, 26]. Some authors observed a
stable [12] or even increased value of spine BMD [13, 25].
In the reported longitudinal study, the majority of studied
women presented BMD remaining within normal values,
but further observation is necessary in order to verify the
thesis that a decline of BMD may lead to the development of
osteoporosis. In the current study, regarding the baseline and
follow-up spine BMD values, only in two subjects was
osteopenic, and in two patients, T-score for FN was below
a threshold of −1.0. In another study [8], the number of
subjects with developing low bone mass a year after surgery
was bigger: for FN from 1.6 % at baseline to 16.1 % at
follow-up, and for spine, from 9.6 % to 19.3 %. Recently,
fewer nutrient deficiencies are observed after LSG than after
laparoscopic Roux-Y gastric bypass [19, 27], which sup-
ports the clinical value of SG as a method of surgical
treatment of bariatric patients. Also, other recent studies
present data showing that SG is a valuable method in obese
patients, due to several reasons, including cholesterol profile
[17], diabetes [18], and weight loss [19].
In a prospective observation, one should take into con-
sideration the precision of used methods; especially, when
the differences between baseline and follow-up values are
not big, a precise evaluation of results in individual patients
may provide important clinical data. Theoretically, a bigger
weight loss should cause a more significant decrease in
BMD. In our study, we proved that a greater decline in body
weight correlated borderline significantly with a smaller
decrease in FN BMD and, significantly, with TH BMD
decrease. That observation suggests that weight loss plays
an essential role in bone loss after bariatric surgery.
Our study has got several limitations: only women were
observed, the follow-up was short, and the results of differ-
ent surgical techniques were not directly compared. The
study design did not include other factors potentially influ-
encing bone metabolism and status (bone markers, vitamin
D, and adipokines). However, irrespective to the pathophys-
iology of changes in bone metabolism, a significant de-
crease in bone densitometric variables was observed in a
considerable part of studied women, especially for the prox-
imal femur.
Fig. 8 Individual values of
BMD for total hip during the
period of observation. BMD
bone mineral density
OBES SURG (2012) 22:1068–1076 1075In conclusion, laparoscopy sleeve gastrectomy proved as
an efficient method to decrease body weight with a parallel
decline in bone mineral density.
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